XERS
Xeris Biopharma Holdings, Inc.Company with tickers: XERS
CIK
1867096
CUSIP
98422E103
Shares Outstanding
172,642,055
13F Activity (30d)
2 filings
1 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-11 | 2026-06-10 | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2025-12-31 | |
| 8-K | 2026-04-21 | 2026-04-20 | |
| 8-K | 2026-03-02 | — | |
| 10-K | 2026-03-02 | 2025-12-31 | |
| 8-K | 2026-02-27 | 2026-02-26 | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-01 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-06-03 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-23 | 2024-12-31 | |
| 8-K | 2025-03-28 | — | |
| 8-K | 2025-03-06 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-02-24 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-11-08 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-08-02 | 2024-08-01 | |
| 8-K | 2024-07-08 | 2024-07-07 | |
| 8-K | 2024-06-05 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-23 | 2024-06-05 | |
| 10-K | 2024-03-06 | 2023-12-31 | |
| 8-K | 2024-03-06 | 2024-03-05 | |
| 8-K | 2024-01-04 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-10-16 | — | |
| 8-K | 2023-09-29 | — | |
| 8-K | 2023-09-27 | 2023-09-26 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-06-28 | — | |
| 8-K | 2023-06-07 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — | |
| DEF 14A | 2023-04-26 | 2022-12-31 |
Showing 1–50 of 75 filings